A0A6V7AMQ7 (A0A6V7AMQ7_SARS2) Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Nucleocapsid phosphoprotein UniProtKBInterProInteractive Modelling
419 aa; Sequence (Fasta) ;
4 identical sequences: Severe acute respiratory syndrome coronavirus 2: P0DTC9, A0A6C0T6Z7, A0A6B9VLF5, A0A6V7AN48
It is possible new templates exist for this target since these models were created.
Available Structures
70 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal Structure of Human Fab S24-202 in the complex with the N-terminal Domain of Nucleocapsid pr… |
Heteromer P0DTC9; | 100 | 9×EDO; 12×IOD; 1×PO4; | |||
| Structure of the SARS-CoV-2 N protein RNA-binding domain bound to single-domain antibody C2 |
Heteromer P0DTC9; | 100 | 1×SO4; | |||
| Crystal Structure of Human Fab S24-1063 in the Complex with the N-teminal Domain of Nucleocapsid Pr… |
Heteromer P0DTC9; | 100 | 4×EDO; | |||
| Structure of the SARS-CoV-2 N protein RNA-binding domain bound to single-domain antibody B6 |
Heteromer P0DTC9; | 100.0 | ||||
| Crystal Structure of Human Fab S24-188 in the complex with the N-teminal Domain of Nucleocapsid pro… |
Heteromer P0DTC9; | 100.0 | ||||
| Complex structure of a human monoclonal antibody with SARS-CoV-2 nucleocapsid protein NTD |
Heteromer P0DTC9; | 100 | 1×ZN; | |||
| Crystal Structure of Human Fab S24-1379 in the Complex with the N-teminal Domain of Nucleocapsid Pr… |
Heteromer P0DTC9; | 100 | ||||
| Crystal structure of the SARS-CoV-2 nucleocapsid protein N-terminal domain in complex with Ubl1 |
Heteromer P0DTC9; P0DTD1; | 100 | ||||
| Two monobodies recognizing the conserved epitopes of SARS-CoV-2 N antigen applicable to the broad C… |
Heteromer P0DTC9; | 100.0 | ||||
| Crystal Structure of Human Fab S24-1564 in the complex with the N-terminal Domain of Nucleocapsid p… |
Heteromer P0DTC9; | 100.0 | 7×EDO; 6×CL; | |||
| Two monobodies recognizing the conserved epitopes of SARS-CoV-2 N antigen applicable to the broad C… |
Heteromer P0DTC9; | 100 | 1×SO4; | |||
| Structure of the SARS-CoV-2 N protein C-terminal domain bound to single-domain antibody E2 |
Heteromer P0DTC9; | 100 | ||||
| Structure of SARS-CoV-2 nucleoprotein in dynamic complex with its viral partner nsp3a |
Heteromer P0DTC9; P0DTD1; | 100 | ||||
| Crystal Structure of the G3BP1 NTF2-like domain bound to the IDR1 of SARS-CoV-2 nucleocapsid protei… |
Heteromer P0DTC9; Q13283; | 100 | ||||
| Crystal Structure of the G3BP1 NTF2-like domain bound to the IDR1 of SARS-CoV-2 nucleocapsid protein |
Heteromer P0DTC9; Q13283; | 100 | ||||
| SARS-CoV-2 Nucleocapsid phosphopeptide 201-210 bound to human 14-3-3 sigma |
Heteromer P0DTC9; P31947; | 100 | 3×CL; | |||
| Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N222-230 |
Heteromer P0DTC9; P61769; Q861F7; | 100 | 2×CD; 2×CA; 1×EDO; | |||
| Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N316-324 |
Heteromer P0DTC9; P61769; Q861F7; | 100 | 1×ACT; 2×CD; 4×NA; | |||
| A COVID-19 T-cell response detection method based on a newly identified human CD8+ T cell epitope f… |
Heteromer A0A6M6CC39; P0DTC9; P61769; | 100 | ||||
| Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N159-167 |
Heteromer P0DTC9; P61769; Q861F7; | 100 | ||||
| Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N138-146 |
Heteromer P0DTC9; P61769; Q861F7; | 100 | 2×CD; 1×ACT; | |||
| Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N351-359 |
Heteromer P0DTC9; P61769; Q861F7; | 100 | 3×3NI; 3×CL; 1×CD; | |||
| Crystal Structure of the G3BP1 NTF2-like domain bound to the IDR1 of SARS-CoV-2 nucleocapsid protei… |
Heteromer P0DTC9; Q13283; | 88.89 | ||||
| HLA-B*07:02 in complex with SARS-CoV-2 nucleocapsid peptide N105-113 |
Heteromer P01889; P0DTC9; P61769; | 100 | 3×CL; | |||
| SARS-CoV-2 specific T cell receptor |
Heteromer P0DTC9; P61769; U5YKE0; | 100 | ||||
| SARS-CoV-2 Nucleocapsid phosphopeptide 193-200 bound to human 14-3-3 sigma |
Heteromer P0DTC9; P31947; | 100 | 4×PEG; 2×GOL; 4×BR; 1×TRS; | |||
| 14-3-3 in complex with SARS-COV2 N phospho-peptide |
Heteromer P0DTC9; P63104; | 100 | 2×ACT; 1×GOL; 1×BEZ; | |||
| Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N226-234 |
Heteromer P0DTC9; P61769; Q861F7; | 100 | 2×CD; 1×NA; 1×ACT; | |||
| GQTVTK segment from the Nucleoprotein of SARS-CoV-2, residues 243-248 | homo-18-mer | 100 | ||||
| AALALL segment from the Nucleoprotein of SARS-CoV-2, residues 217-222, crystal form 2 | homo-18-mer | 100 | 36×PG4; | |||
| Crystal structure of N-terminal domain of Nucleocapsid protein of SARS-CoV-2 | homo-16-mer | 100 | 8×GOL; | |||
| GSQASS segment from the Nucleoprotein of SARS-CoV-2, residues 179-184 | homo-16-mer | 100 | ||||
| AALALL SEGMENT FROM THE NUCLEOPROTEIN OF SARS-COV-2, RESIDUES 217-222, CRYSTAL FORM 1 | homo-12-mer | 100 | 18×TFA; | |||
| Crystal structure of SARS-CoV2 N-NTD complexed with 5-Benzyloxygramine | homo-4-mer | 100.0 | 1×DJU; | |||
| Crystal structure of SARS-CoV2 N-NTD complexed with 5-Benzyloxygramine derivative (P3-8) | homo-4-mer | 100.0 | 1×U2H; | |||
| Crystal structure of RNA-binding domain of nucleocapsid phosphoprotein from SARS CoV-2, monoclinic … | homo-4-mer | 100.0 | 4×ZN; 2×MES; | |||
| Crystal structure of RNA binding domain of nucleocapsid phosphoprotein from SARS coronavirus 2 | homo-4-mer | 100 | 4×MES; 4×CL; 4×ZN; 4×GOL; | |||
| Crystal structure of SARS-CoV-2 N-NTD | homo-4-mer | 100 | 4×ZN; 4×MES; | |||
| SARS-CoV-2 Nucleocapsid dimer structure determined from COVID-19 patients | homo-2-mer | 100 | ||||
| Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosphoprotein from SARS-CoV-2,… | homo-2-mer | 100 | ||||
| Crystal Structure of SARS-CoV-2 N-CTD in complex with GTP (I) | homo-2-mer | 100 | ||||
| 1.45 Angstrom Resolution Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosph… | homo-2-mer | 100 | ||||
| Crystal structure of SARS-CoV-2 nucleocapsid protein C-terminal RNA binding domain | homo-2-mer | 100 | 3×PEG; | |||
| Structure of SARS-CoV-2 Nucleocapsid dimerization domain, P21 form | homo-2-mer | 100 | 3×SO4; | |||
| Crystal structure of the C-terminal domain of SARS-CoV-2 nucleocapsid protein | homo-2-mer | 100 | 1×ACT; 1×PEG; | |||
| Crystal Structure of SARS-CoV-2 N-CTD in complex with GTP (II) | homo-2-mer | 100 | 1×GTP; 1×GOL; | |||
| Structure of SARS-CoV-2 Nucleocapsid dimerization domain, P1 form | homo-2-mer | 100 | ||||
| Crystal structure of SARS-CoV-2 N-CTD | homo-2-mer | 100 | ||||
| 1.3 Angstrom Resolution Crystal Structure of SARS-CoV-2 Nucleocapsid dimerization domain, pH 8.5 | homo-2-mer | 100 | ||||
| Crystal structure of 2019-nCoV nucleocapsid C-terminal domain (CTD) protein | homo-2-mer | 100 | ||||
| Crystal structure of SARS-CoV-2 nucleocapsid protein C-terminal domain complexed with Chicoric acid | homo-2-mer | 100 | 1×GKP; 1×PEG; 1×GOL; 1×NA; | |||
| Crystal structure of SARS-CoV-2 nucleocapsid protein C-terminal domain | homo-2-mer | 100 | 1×GOL; | |||
| Crystal structure of SARS-CoV-2 N-CTD in complex with GMP | homo-2-mer | 100 | 1×SCN; 2×5GP; 5×K; 3×CL; | |||
| 1.6 Angstrom Resolution Crystal Structure of SARS-CoV-2 Nucleocapsid dimerization domain, pH 5.0 | homo-2-mer | 100 | ||||
| 2.05 Angstrom Resolution Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosph… | homo-2-mer | 100 | 2×CL; | |||
| Crystal structure of SARS-CoV-2 nucleocapsid protein C-terminal RNA binding domain at 2.0A resoluti… | homo-2-mer | 100 | 6×PO4; 1×CL; | |||
| SARS-CoV-2 nucleocapsid protein C-terminal domain (dodecamer) | homo-2-mer | 100 | ||||
| Crystal structure of SARS-CoV-2 N-CTD | homo-2-mer | 100 | 1×PO4; | |||
| Nucleocapsid monomer structure from SARS-CoV-2 | monomer | 100 | ||||
| The SARS-CoV-2 nucleocapsid phosphoprotein N-terminal domain in complex with 10mer ssRNA | monomer | 100 | ||||
| The N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein | monomer | 100 | ||||
| The SARS-CoV-2 nucleocapsid phosphoprotein N-terminal domain in complex with 7mer dsRNA | monomer | 100 | ||||
| SARS-CoV-2 Nucleocapsid N-terminal domain (N-NTD) protein | monomer | 100 | ||||
| Crystal structure of 2019-nCoV nucleocapsid N-terminal domain (NTD) protein | monomer | 100 | ||||
| Crystal structure of the N-terminal domain of SARS-CoV-2 nucleocapsid protein | monomer | 100 | ||||
| Structure of SARS-CoV-2 Nucleocapsid Protein N-Terminal Domain | monomer | 100 | ||||
| Crystal structure of SARS-CoV2 N-NTD | monomer | 100.0 | ||||
| Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain | monomer | 100.0 | ||||
| Crystal structure of SARS-CoV-2 N-NTD and dsRNA complex | monomer | 100.0 | 2×EDO; | |||
| Crystal structure of SARS-Cov-2 nucleocapsid N-terminal domain (NTD) protein,pH8.0 | monomer | 100 | ||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2ofz.1.A | monomer | 0.74 | 92.06 | |||
| 4ud1.1.A | monomer | 0.68 | 55.41 | |||
| 6wzq.2.B | monomer | 0.60 | 100.00 | |||